Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss

J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e24-e26. doi: 10.1111/jdv.16765. Epub 2020 Jul 9.

Authors

P M Ramos¹, P Gohad², J McCoy², C Wambier³, A Goren²

Affiliations

¹ Department of Dermatology and Radiotherapy, São Paulo State University (UNESP), Botucatu, SP, Brazil.
² Applied Biology, Irvine, CA, USA.
³ Department of Dermatology, The Warren Alpert School, Brown University, Providence, RI, USA.

PMID: 32567076
DOI: 10.1111/jdv.16765

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Alopecia* / drug therapy
Alopecia* / genetics
Arylsulfotransferase / therapeutic use
Female
Humans
Minoxidil* / therapeutic use
Sulfotransferases* / genetics
Sulfotransferases* / therapeutic use
Treatment Outcome

Substances

Minoxidil
Sulfotransferases
minoxidil sulfotransferase
Arylsulfotransferase
SULT1A1 protein, human